Related Experiment Video
Updated: Jun 21, 2026

Genome-wide Screen for miRNA Targets Using the MISSION Target ID Library
Published on: April 6, 2012
Breast cancer metastasis suppressor 1 coordinately regulates metastasis-associated microRNA expression
Mick D Edmonds1, Douglas R Hurst, Kedar S Vaidya
1Department of Pathology, University of Alabama at Birmingham, Birmingham, AL 35294-0019, USA.
Abstract:
Breast cancer metastasis suppressor 1 (BRMS1) suppresses metastasis of multiple tumor types without blocking tumorigenesis. BRMS1 forms complexes with SIN3, histone deacetylases and selected transcription factors that modify metastasis-associated gene expression (e.g., EGFR, OPN, PI4P5K1A, PLAU). microRNA (miRNA) are a recently discovered class of regulatory, noncoding RNA, some of which are involved in neoplastic progression. Based on these data, we hypothesized that BRMS1 may also exert some of its antimetastatic effects by regulating miRNA expression. MicroRNA arrays were done comparing small RNAs that were purified from metastatic MDA-MB-231 and MDA-MB-435 and their nonmetastatic BRMS1-transfected counterparts. miRNA expression changed by BRMS1 were validated using SYBR Green RT-PCR. BRMS1 decreased metastasis-promoting (miR-10b, -373 and -520c) miRNA, with corresponding reduction of their downstream targets (e.g., RhoC which is downstream of miR-10b). Concurrently, BRMS1 increased expression of metastasis suppressing miRNA (miR-146a, -146b and -335). Collectively, these data show that BRMS1 coordinately regulates expression of multiple metastasis-associated miRNA and suggests that recruitment of BRMS1-containing SIN3:HDAC complexes to, as yet undefined, miRNA promoters might be involved in the regulation of cancer metastasis.
Insights
Breast cancer metastasis suppressor 1 (BRMS1) regulates microRNA (miRNA) expression to inhibit cancer spread. BRMS1 decreases metastasis-promoting miRNAs and increases metastasis-suppressing miRNAs, impacting tumor progression.
Area of Science:
- Molecular oncology
- Cancer epigenetics
- RNA biology
Background:
- Breast cancer metastasis suppressor 1 (BRMS1) is a known inhibitor of metastasis in various cancers.
- BRMS1 functions by forming complexes with SIN3 and histone deacetylases to alter gene expression.
- MicroRNAs (miRNAs) are regulatory RNAs implicated in cancer progression.
Purpose of the Study:
- To investigate whether BRMS1 exerts its antimetastatic effects by regulating miRNA expression.
- To identify specific miRNAs regulated by BRMS1 in breast cancer cells.
Main Methods:
- Comparative microRNA array analysis of metastatic and nonmetastatic breast cancer cell lines (MDA-MB-231, MDA-MB-435) with and without BRMS1 transfection.
- Validation of differentially expressed miRNAs using SYBR Green RT-PCR.
Main Results:
- BRMS1 transfection led to decreased expression of metastasis-promoting miRNAs (e.g., miR-10b, -373, -520c) and their downstream targets (e.g., RhoC).
- BRMS1 transfection resulted in increased expression of metastasis-suppressing miRNAs (e.g., miR-146a, -146b, -335).
Conclusions:
- BRMS1 coordinately regulates the expression of multiple metastasis-associated miRNAs.
- BRMS1's regulation of miRNA expression is a key mechanism contributing to its antimetastatic activity.
- BRMS1-containing SIN3:HDAC complexes may be recruited to miRNA promoters to modulate cancer metastasis.
Related Concept Videos
MicroRNAs
MicroRNAs
MicroRNAs
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
